Essity AB (ESSITY-B.ST) is a leading global hygiene and health company with a portfolio of strong brands in tissue, personal care, and incontinence products. The company is undergoing a significant margin recovery driven by cost savings, premiumization, and pricing discipline. With a robust balance sheet and a dividend yield of ~3.5%, Essity offers a defensive yet growth-oriented profile.
12-Month Catalysts:
- Margin expansion from restructuring and raw material cost tailwinds.
- Accelerating growth in emerging markets, particularly in Latin America and Asia.
- Potential portfolio optimization, including divestiture of non-core assets.
Key Risks:
- Input cost inflation (pulp, energy) could pressure margins.
- Intense competition from private labels and peers like Procter & Gamble.
Valuation: Essity trades at ~15x forward P/E, a discount to its historical average and to peers like Kimberly-Clark (~18x). With expected EPS growth of 8-10% annually, the valuation is attractive.
Balance Sheet: Net debt/EBITDA of ~1.5x, strong free cash flow generation, and investment-grade credit rating.
Disclaimer: This is not financial advice. Investing involves risk, including loss of principal. Do your own research.